Merit Medical Systems To Announce Second Quarter 2025 Results On July 30, 2025
Merit Medical Systems (NASDAQ: MMSI), a leading healthcare technology manufacturer, has scheduled its second quarter 2025 financial results announcement for July 30, 2025, after market close. The company will host an investor conference call the same day at 5:00 p.m. Eastern Time.
Founded in 1987, Merit Medical specializes in proprietary medical devices for interventional, diagnostic, and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care, and endoscopy. The company maintains a global presence with over 800 sales and clinical support professionals and approximately 7,300 employees worldwide.
Merit Medical Systems (NASDAQ: MMSI), un produttore leader nel settore della tecnologia sanitaria, ha programmato l'annuncio dei risultati finanziari del secondo trimestre 2025 per il 30 luglio 2025, dopo la chiusura del mercato. La societ脿 terr脿 una conference call per gli investitori lo stesso giorno alle 17:00 ora della costa orientale.
Fondata nel 1987, Merit Medical 猫 specializzata in dispositivi medici proprietari per procedure interventistiche, diagnostiche e terapeutiche, in particolare in cardiologia, radiologia, oncologia, terapia intensiva ed endoscopia. L'azienda ha una presenza globale con oltre 800 professionisti nelle vendite e nel supporto clinico e circa 7.300 dipendenti in tutto il mondo.
Merit Medical Systems (NASDAQ: MMSI), un fabricante l铆der en tecnolog铆a sanitaria, ha programado el anuncio de sus resultados financieros del segundo trimestre de 2025 para el 30 de julio de 2025, despu茅s del cierre del mercado. La compa帽铆a realizar谩 una conferencia telef贸nica para inversores ese mismo d铆a a las 5:00 p.m. hora del Este.
Fundada en 1987, Merit Medical se especializa en dispositivos m茅dicos patentados para procedimientos intervencionistas, diagn贸sticos y terap茅uticos, especialmente en cardiolog铆a, radiolog铆a, oncolog铆a, cuidados cr铆ticos y endoscop铆a. La empresa cuenta con presencia global con m谩s de 800 profesionales de ventas y soporte cl铆nico y aproximadamente 7,300 empleados en todo el mundo.
Merit Medical Systems (NASDAQ: MMSI)電� 靹犽弰鞝侅澑 鞚橂 旮办垹 鞝滌“鞐呾泊搿滌劀 2025雲� 2攵勱赴 鞛 鞁れ爜 氚滍憸毳� 2025雲� 7鞗� 30鞚� 鞁滌灔 毵堦皭 頉勳棎 鞓堨爼頃橁碃 鞛堨姷雼堧嫟. 須岇偓電� 臧欖潃 雮� 霃欕秬 響滌鞁� 鞓ろ泟 5鞁�鞐� 韴瀽鞛� 旎嵓霟办姢 旖滌潉 臧滌禍頃� 鞓堨爼鞛呺媹雼�.
1987雲勳棎 靹る霅� Merit Medical鞚� 鞁灔頃�, 氚╈偓靹犿暀, 膦呾枒頃�, 欷戫櫂鞛� 旃橂 氚� 雮挫嫓瓴� 攵勳暭鞐愳劀 韸鬼瀳 臧滌瀰鞝�, 歆勲嫧鞝�, 旃橂鞝� 鞝堨皑毳� 鞙勴暅 霃呾瀽鞝侅澑 鞚橂旮瓣赴 鞝勲 須岇偓鞛呺媹雼�. 鞝� 靹戈硠鞐� 瓯胳硱 800氇� 鞚挫儊鞚� 鞓侅梾 氚� 鞛勳儊 歆�鞗� 鞝勲臧�鞕� 鞎� 7,300氇呾潣 歆侅洂鞚� 氤挫湢頃橁碃 鞛堨姷雼堧嫟.
Merit Medical Systems (NASDAQ : MMSI), un fabricant leader de technologies de sant茅, a pr茅vu d鈥檃nnoncer ses r茅sultats financiers du deuxi猫me trimestre 2025 le 30 juillet 2025, apr猫s la cl么ture du march茅. La soci茅t茅 tiendra une conf茅rence t茅l茅phonique pour les investisseurs le m锚me jour 脿 17h00, heure de l鈥橢st.
Fond茅e en 1987, Merit Medical est sp茅cialis茅e dans les dispositifs m茅dicaux propri茅taires pour les proc茅dures interventionnelles, diagnostiques et th茅rapeutiques, notamment en cardiologie, radiologie, oncologie, soins intensifs et endoscopie. L鈥檈ntreprise est pr茅sente 脿 l鈥櫭ヽhelle mondiale avec plus de 800 professionnels des ventes et du support clinique et environ 7 300 employ茅s dans le monde.
Merit Medical Systems (NASDAQ: MMSI), ein f眉hrender Hersteller von Medizintechnik, hat die Bekanntgabe der Finanzergebnisse f眉r das zweite Quartal 2025 f眉r den 30. Juli 2025 nach B枚rsenschluss geplant. Das Unternehmen wird am selben Tag um 17:00 Uhr Eastern Time eine Telefonkonferenz f眉r Investoren abhalten.
Gegr眉ndet im Jahr 1987, spezialisiert sich Merit Medical auf propriet盲re medizinische Ger盲te f眉r interventionelle, diagnostische und therapeutische Verfahren, insbesondere in den Bereichen Kardiologie, Radiologie, Onkologie, Intensivmedizin und Endoskopie. Das Unternehmen ist weltweit mit 眉ber 800 Vertriebs- und klinischen Supportmitarbeitern und etwa 7.300 Mitarbeitern weltweit vertreten.
- None.
- None.
SOUTH JORDAN, Utah, July 03, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today that it will release its financial results for the quarter ended June 30, 2025, after the close of the stock market on Wednesday, July 30, 2025. Merit plans to hold its investor conference call on the same day (Wednesday, July 30, 2025) at 5:00 p.m. Eastern (4:00 p.m. Central, 3:00 p.m. Mountain, and 2:00 p.m. Pacific).
To access the conference call, please pre-register using the following . Registrants will receive confirmation with dial-in details.
A live webcast and slide deck can be accessed using this . A link to both register for the conference call and view the webcast will be made available at www.merit.com.
ABOUT MERIT
Founded in 1987, Merit Medical Systems, Inc. is engaged in the development, manufacture, and distribution of proprietary medical devices used in interventional, diagnostic, and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care, and endoscopy. Merit serves customers worldwide with a domestic and international sales force and clinical support team totaling more than 800 individuals. Merit employs approximately 7,300 people worldwide.
| Contacts: | 听 |
| 听 | 听 |
| PR/Media Inquiries: | Investor Inquiries: |
| Sarah Comstock | Mike Piccinino, CFA, IRC |
| Merit Medical | ICR Healthcare |
| +1-801-432-2864听 | +1-443-213-0509 |
| [email protected]听 | [email protected]听 |
FAQ
When will Merit Medical (MMSI) report Q2 2025 earnings?
How can investors access Merit Medical's Q2 2025 earnings call?
What are Merit Medical's main business segments?
How many employees does Merit Medical (MMSI) have?
